把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $85.39M |
| -$29.53M |
| -$25.72M |
| 30.1% |
| -42.2% |
| 78 |
| 尚无授权文本 |
| GE GENERAL ELECTRIC CO | 2026-06-30 | 3/3 | $13.35B | $2.37B | — | — | — | 108 | 尚无授权文本 |
| GM General Motors Co | 2026-06-30 | 3/3 | $43.76B | $1.31B | $5.85B | — | 3.3% | 94 | 尚无授权文本 |
| GPC GENUINE PARTS CO | 2026-06-30 | 3/3 | $6.54B | $227.56M | $258.72M | 37.8% | — | 98 | 尚无授权文本 |
| MYGN MYRIAD GENETICS INC | 2026-06-30 | 3/3 | $190.7M | -$43.2M | — | 66.6% | -20.4% | 90 | 尚无授权文本 |
| POR PORTLAND GENERAL ELECTRIC CO /OR/ | 2026-06-30 | 3/3 | $814M | $68M | -$147M | — | 14.9% | 103 | 尚无授权文本 |
| REGN REGENERON PHARMACEUTICALS, INC. | 2026-06-30 | 3/3 | $4.29B | $1.3B | — | — | 30.1% | 82 | 尚无授权文本 |
| RGEN REPLIGEN CORP | 2026-06-30 | 3/3 | — | $5.01M | $51.02M | — | — | 78 | 尚无授权文本 |
| THRM Gentherm Inc | 2026-06-30 | 3/3 | $416.17M | $4.42M | -$11.93M | 23.2% | 2.6% | 90 | 尚无授权文本 |
| GIS GENERAL MILLS INC | 2026-05-31 | 3/3 | $4.61B | -$2.01B | $1.63B | 34.8% | 4.8% | 91 | 尚无授权文本 |
| NEOG NEOGEN CORP | 2026-05-31 | 3/3 | $870.4M | -$7.9M | — | 46.9% | -2.5% | 96 | 尚无授权文本 |
| GCO GENESCO INC | 2026-05-02 | 3/3 | $487.03M | -$14.81M | -$118.19M | 47.0% | -3.2% | 91 | 尚无授权文本 |
| DG DOLLAR GENERAL CORP | 2026-05-01 | 3/3 | $10.79B | $444.13M | — | 31.6% | 5.9% | 74 | 尚无授权文本 |
| CASY CASEYS GENERAL STORES INC | 2026-04-30 | 3/3 | $17.56B | $714.45M | $721.62M | — | — | 80 | 尚无授权文本 |
| ENGN enGene Therapeutics Inc. | 2026-04-30 | 3/3 | — | -$30.23M | -$59.65M | — | — | 53 | 尚无授权文本 |
| GD GENERAL DYNAMICS CORP | 2026-04-05 | 3/3 | $13.48B | $1.13B | $1.95B | — | 10.5% | 70 | 尚无授权文本 |
| GEN Gen Digital Inc. | 2026-04-03 | 3/3 | $5B | $973M | $1.52B | 78.5% | 42.4% | 94 | 尚无授权文本 |
| AGEN AGENUS INC | 2026-03-31 | 3/3 | $33.74M | $39.21M | -$35.95M | 100.0% | 44.6% | 93 | 尚无授权文本 |
| ALLO Allogene Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.61M | -$12.92M | — | — | 88 | 尚无授权文本 |
| AMGN AMGEN INC | 2026-03-31 | 3/3 | $8.62B | $1.82B | $1.48B | 68.2% | 30.9% | 88 | 尚无授权文本 |
| AXIN Axiom Intelligence Acquisition Corp 1 | 2026-03-31 | 3/3 | — | $1.52M | — | — | — | 12 | 尚无授权文本 |
| AXINU Axiom Intelligence Acquisition Corp 1 | 2026-03-31 | 3/3 | — | $1.52M | — | — | — | 12 | 尚无授权文本 |
| BESS Bimergen Energy Corp | 2026-03-31 | 3/3 | — | -$3.75M | — | — | — | 58 | 尚无授权文本 |
| BGLC BioNexus Gene Lab Corp | 2026-03-31 | 3/3 | $22,842 | -$543,575 | -$147,996 | -3.5% | -2366.2% | 70 | 尚无授权文本 |
| BIIB BIOGEN INC. | 2026-03-31 | 3/3 | $2.48B | $319.5M | $594.3M | 73.3% | — | 85 | 尚无授权文本 |
| BNGO Bionano Genomics, Inc. | 2026-03-31 | 3/3 | $6.69M | -$8.3M | — | 48.6% | -118.1% | 112 | 尚无授权文本 |
| CATY CATHAY GENERAL BANCORP | 2026-03-31 | 3/3 | — | $86.89M | $96.03M | — | — | 67 | 尚无授权文本 |
| CCOI COGENT COMMUNICATIONS HOLDINGS, INC. | 2026-03-31 | 3/3 | — | -$39.54M | -$31.41M | — | — | 96 | 尚无授权文本 |
| COGT Cogent Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$97.35M | -$87.33M | — | — | 83 | 尚无授权文本 |
| EBS Emergent BioSolutions Inc. | 2026-03-31 | 3/3 | $156.1M | $6.8M | -$36.2M | 53.9% | 6.7% | 135 | 尚无授权文本 |
| FFAI FARADAY FUTURE INTELLIGENT ELECTRIC INC. | 2026-03-31 | 3/3 | $512,000 | -$38.86M | -$31.69M | -2222.3% | -7012.7% | 268 | 尚无授权文本 |
| FPS Forgent Power Solutions, Inc. | 2026-03-31 | 3/3 | $378.71M | $18.29M | -$49.42M | 34.6% | 10.4% | 6 | 尚无授权文本 |
| G Genpact LTD | 2026-03-31 | 3/3 | $1.3B | $147.99M | -$47.47M | 36.4% | 15.3% | 71 | 尚无授权文本 |
| GEL GENESIS ENERGY LP | 2026-03-31 | 3/3 | $446.56M | $6.8M | — | — | 17.2% | 77 | 尚无授权文本 |
| GENB Generate Biomedicines, Inc. | 2026-03-31 | 3/3 | $7.22M | -$61.45M | -$84.17M | — | -887.5% | 3 | 尚无授权文本 |
| GENC GENCOR INDUSTRIES INC | 2026-03-31 | 3/3 | — | $3.84M | — | — | — | 77 | 尚无授权文本 |
| GENK GEN Restaurant Group, Inc. | 2026-03-31 | 3/3 | $53.9M | -$1.17M | -$667,000 | — | -13.4% | 41 | 尚无授权文本 |
| GIPR GENERATION INCOME PROPERTIES, INC. | 2026-03-31 | 3/3 | $2.18M | -$2.13M | — | — | -56.6% | 98 | 尚无授权文本 |
| GNE Genie Energy Ltd. | 2026-03-31 | 3/3 | $142.31M | $2.78M | — | 21.0% | 1.3% | 97 | 尚无授权文本 |
| GNK GENCO SHIPPING & TRADING LTD | 2026-03-31 | 3/3 | $114.43M | $9.31M | $15.29M | — | 11.6% | 86 | 尚无授权文本 |
| GNLX GENELUX Corp | 2026-03-31 | 3/3 | — | -$8.93M | -$6.98M | — | — | 45 | 尚无授权文本 |
| GNPX Genprex, Inc. | 2026-03-31 | 3/3 | — | -$4.46M | — | — | — | 136 | 尚无授权文本 |
| GNRC GENERAC HOLDINGS INC. | 2026-03-31 | 3/3 | $1.06B | $73.25M | $89.89M | 38.7% | 11.1% | 67 | 尚无授权文本 |
| GNSS Genasys Inc. | 2026-03-31 | 3/3 | — | $723,000 | -$2.15M | — | — | 80 | 尚无授权文本 |
| GNTX GENTEX CORP | 2026-03-31 | 3/3 | $675.44M | $98.46M | — | 33.8% | 18.3% | 59 | 尚无授权文本 |
| GNW GENWORTH FINANCIAL INC | 2026-03-31 | 3/3 | $1.78B | $47M | — | — | — | 101 | 尚无授权文本 |
| GPAC General Purpose Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.68M | — | — | — | 5 | 尚无授权文本 |
| GPACU General Purpose Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.68M | — | — | — | 5 | 尚无授权文本 |
| GRWG GrowGeneration Corp. | 2026-03-31 | 3/3 | $38.39M | -$4.92M | — | 25.4% | -13.7% | 134 | 尚无授权文本 |
| IMA ImageneBio, Inc. | 2026-03-31 | 3/3 | — | -$10.62M | — | — | — | 73 | 尚无授权文本 |
| INBS INTELLIGENT BIO SOLUTIONS INC. | 2026-03-31 | 3/3 | $1.06M | -$2.86M | -$8.87M | 50.5% | -277.8% | 178 | 尚无授权文本 |
| INGN Inogen Inc | 2026-03-31 | 3/3 | $72.4M | -$8.32M | -$6.9M | 52.3% | -12.9% | 94 | 尚无授权文本 |
| IPM INTELLIGENT PROTECTION MANAGEMENT CORP. | 2026-03-31 | 3/3 | $6.35M | -$660,214 | -$265,920 | 48.7% | -12.1% | 81 | 尚无授权文本 |
| IRD Opus Genetics, Inc. | 2026-03-31 | 3/3 | $2.16M | -$65.54M | — | — | -665.9% | 120 | 尚无授权文本 |
| LGN Legence Corp. | 2026-03-31 | 3/3 | $1.04B | $16.09M | $102.29M | 17.9% | 2.2% | 13 | 尚无授权文本 |
| MCY MERCURY GENERAL CORP | 2026-03-31 | 3/3 | $1.54B | $190.42M | — | 99.7% | — | 66 | 尚无授权文本 |
| MGNX MACROGENICS INC | 2026-03-31 | 3/3 | $20.78M | -$36.77M | -$36.16M | — | -161.0% | 94 | 尚无授权文本 |
| MGX Metagenomi Therapeutics, Inc. | 2026-03-31 | 3/3 | $1.25M | -$23.06M | -$21.2M | — | -1970.1% | 31 | 尚无授权文本 |
| NAGE Niagen Bioscience, Inc. | 2026-03-31 | 3/3 | $31.47M | $6.32M | — | 63.5% | 5.0% | 91 | 尚无授权文本 |
| NEO NEOGENOMICS INC | 2026-03-31 | 3/3 | — | -$17.11M | -$13.14M | — | — | 107 | 尚无授权文本 |
| NGNE Neurogene Inc. | 2026-03-31 | 3/3 | — | -$30.93M | -$26.4M | — | — | 100 | 尚无授权文本 |
| NIQ NIQ Global Intelligence plc | 2026-03-31 | 3/3 | $1.07B | -$90.1M | -$66.8M | — | -1.0% | 11 | 尚无授权文本 |
| OCGN Ocugen, Inc. | 2026-03-31 | 3/3 | $1.53M | -$19.18M | -$21.8M | — | -1163.7% | 196 | 尚无授权文本 |
| OCTV Octave Intelligence plc | 2026-03-31 | 3/3 | $386.5M | $47.38M | $113.07M | 77.0% | 16.5% | 3 | 尚无授权文本 |
| OGEN ORAGENICS INC | 2026-03-31 | 3/3 | — | -$2.2M | — | — | — | 158 | 尚无授权文本 |
| ORGO Organogenesis Holdings Inc. | 2026-03-31 | 3/3 | $37.23M | -$53.16M | $17.98M | — | -185.1% | 78 | 尚无授权文本 |
| PEPG PepGen Inc. | 2026-03-31 | 3/3 | — | -$17.76M | -$18.43M | — | — | 81 | 尚无授权文本 |
| PGEN PRECIGEN, INC. | 2026-03-31 | 3/3 | $23.25M | -$7.93M | -$44.09M | — | -25.8% | 88 | 尚无授权文本 |
| RARE Ultragenyx Pharmaceutical Inc. | 2026-03-31 | 3/3 | $136M | -$185M | -$198M | — | -124.3% | 119 | 尚无授权文本 |
| REG REGENCY CENTERS CORP | 2026-03-31 | 3/3 | $412.45M | $128.55M | — | — | 71.9% | 121 | 尚无授权文本 |
| REGCO REGENCY CENTERS CORP | 2026-03-31 | 3/3 | $412.45M | $128.55M | — | — | 71.9% | 121 | 尚无授权文本 |
| REGCP REGENCY CENTERS CORP | 2026-03-31 | 3/3 | $412.45M | $128.55M | — | — | 71.9% | 121 | 尚无授权文本 |
| RGNX REGENXBIO Inc. | 2026-03-31 | 3/3 | $6.39M | -$90.05M | -$77.42M | — | -1304.0% | 86 | 尚无授权文本 |
| SNGX SOLIGENIX, INC. | 2026-03-31 | 3/3 | — | -$2.82M | — | — | — | 92 | 尚无授权文本 |
| TGEN TECOGEN INC. | 2026-03-31 | 3/3 | $6.34M | -$2.12M | -$3.15M | 40.9% | -33.7% | 95 | 尚无授权文本 |
| TSHA Taysha Gene Therapies, Inc. | 2026-03-31 | 3/3 | $0 | -$42.41M | -$40.9M | — | — | 107 | 尚无授权文本 |
| TVGN Tevogen Bio Holdings Inc. | 2026-03-31 | 3/3 | — | -$5.45M | — | — | — | 63 | 尚无授权文本 |
| TXG 10x Genomics, Inc. | 2026-03-31 | 3/3 | $150.84M | -$13.47M | $24.52M | 70.4% | -11.3% | 71 | 尚无授权文本 |
| URGN UroGen Pharma Ltd. | 2026-03-31 | 3/3 | $50.96M | -$23.57M | -$45.37M | 91.9% | -39.8% | 87 | 尚无授权文本 |
| VGNT Versigent PLC | 2026-03-31 | 3/3 | $2.21B | $78M | — | 11.0% | 3.3% | 5 | 尚无授权文本 |
| VTGN Vistagen Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$69.69M | — | — | — | 157 | 尚无授权文本 |
| WGS GeneDx Holdings Corp. | 2026-03-31 | 3/3 | $102.25M | -$63.32M | -$38.86M | 66.7% | -56.2% | 87 | 尚无授权文本 |
| XGN EXAGEN INC. | 2026-03-31 | 3/3 | $17.31M | -$3.97M | -$10.65M | 59.0% | -19.7% | 84 | 尚无授权文本 |
| ADAG Adagene Inc. | 2025-12-31 | 3/3 | $7.67M | -$17.61M | — | — | -279.5% | 69 | 尚无授权文本 |
| AGCC Agencia Comercial Spirits Ltd. | 2025-12-31 | 3/3 | $6.21M | $609,382 | — | 30.4% | 12.6% | 15 | 尚无授权文本 |
| ARGX ARGENX SE | 2025-12-31 | 2/3 | — | $1.29B | — | — | — | 118 | 尚无授权文本 |
| BBVA BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | 2025-12-31 | 2/3 | — | $11.13B | — | — | — | 385 | 尚无授权文本 |
| CGEN COMPUGEN LTD | 2025-12-31 | 3/3 | $72.76M | $35.34M | $31.33M | 87.3% | 43.1% | 82 | 尚无授权文本 |
| EVGN Evogene Ltd. | 2025-12-31 | 2/3 | — | -$7.83M | — | — | — | 159 | 尚无授权文本 |
| GENI Genius Sports Ltd | 2025-12-31 | 3/3 | $669.49M | -$111.58M | $64.54M | 23.0% | -22.6% | 65 | 尚无授权文本 |
| GMAB GENMAB A/S | 2025-12-31 | 2/3 | — | $963M | — | — | — | 412 | 尚无授权文本 |
| GNS Genius Group Ltd | 2025-12-31 | 2/3 | — | -$55.46M | — | — | — | 226 | 尚无授权文本 |
| GNTA Genenta Science S.p.A. | 2025-12-31 | 3/3 | — | -$6.53M | -$6.88M | — | — | 52 | 尚无授权文本 |
| IGIC International General Insurance Holdings Ltd. | 2025-12-31 | 3/3 | $516.88M | $127.15M | — | — | — | 123 | 尚无授权文本 |
| ILAG Intelligent Living Application Group Inc. | 2025-12-31 | 3/3 | $4.49M | -$19.35M | -$2.45M | 2.9% | -430.7% | 35 | 尚无授权文本 |
| LAR Lithium Argentina AG | 2025-12-31 | 2/3 | — | -$76.88M | — | — | — | 133 | 尚无授权文本 |
| LEGN Legend Biotech Corp | 2025-12-31 | 2/3 | — | -$296.8M | — | — | — | 190 | 尚无授权文本 |
| NGEN NERVGEN PHARMA CORP. | 2025-12-31 | 2/3 | — | -$44.12M | — | — | — | 12 | 尚无授权文本 |
| NIVF NewGenIvf Group Ltd | 2025-12-31 | 3/3 | $4.73M | $9.88M | -$11.06M | 20.2% | -226.9% | 52 | 尚无授权文本 |
| NXE NexGen Energy Ltd. | 2025-12-31 | 2/3 | — | -$309.68M | — | — | — | 143 | 尚无授权文本 |
| QGEN QIAGEN N.V. | 2025-12-31 | 3/3 | $2.09B | $424.88M | $453.28M | 62.2% | 22.3% | 78 | 尚无授权文本 |
| RGNT REGENTIS BIOMATERIALS LTD. | 2025-12-31 | 3/3 | — | -$13.65M | — | — | — | 18 | 尚无授权文本 |
| SOPH SOPHiA GENETICS SA | 2025-12-31 | 2/3 | — | -$79M | — | — | — | 78 | 尚无授权文本 |
| TEO TELECOM ARGENTINA SA | 2025-12-31 | 2/3 | — | -$145.3B | — | — | — | 212 | 尚无授权文本 |
| INTJ Intelligent Group Ltd | 2025-11-30 | 3/3 | $18.48M | -$18.18M | -$130,736 | 63.8% | -108.2% | 35 | 尚无授权文本 |
| RGC Regencell Bioscience Holdings Ltd | 2025-06-30 | 3/3 | — | -$3.58M | -$3.27M | — | — | 39 | 尚无授权文本 |
| BBAR Banco BBVA Argentina S.A. | 2024-12-31 | 2/3 | — | $364.82B | — | — | — | 213 | 尚无授权文本 |
| LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima | 2024-12-31 | 2/3 | — | $153.63B | — | — | — | 236 | 尚无授权文本 |
| TNMG TNL Mediagene | 2024-12-31 | 2/3 | — | -$84.98M | — | — | — | 30 | 尚无授权文本 |
| AIO Virtus Artificial Intelligence & Technology Opportunities Fund | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| DTSS Datasea Intelligent Technology Ltd. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| GAM GENERAL AMERICAN INVESTORS CO INC | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust | — | 0/3 | — | — | — | — | — | 4 | 尚无授权文本 |
| GCGR General Catalyst Global Resilience Merger Corp. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| GCGRU General Catalyst Global Resilience Merger Corp. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |
| GOF GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | — | 0/3 | — | — | — | — | — | 6 | 尚无授权文本 |
| GUG Guggenheim Active Allocation Fund | — | 0/3 | — | — | — | — | — | 2 | 尚无授权文本 |
| NBXG Neuberger Next Generation Connectivity Fund Inc. | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| NXG NXG NextGen Infrastructure Income Fund | — | 0/3 | — | — | — | — | — | 8 | 尚无授权文本 |
| TGE Generation Essentials Group | — | 0/3 | — | — | — | — | — | 18 | 尚无授权文本 |